Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $86.70 | Total: $433.50 |
| 1 | 10 | $73.44 | Total: $734.40 |
| 1 | 25 | $62.22 | Total: $1,555.50 |
| 1 | 50 | $53.04 | Total: $2,652.00 |
| 1 | 100 | $45.90 | Total: $4,590.00 |
Overview
Eclazolast (RHC 2871) is a lipophilic anti-allergic compound that inhibits mediator release in a mast cell model.Eclazolast inhibits extracellular secretion by affecting only the direct processes associated with Fc(epsilon)RI in the cell.The effect of Eclazolast is highly dependent on the concentration of antigen that triggers the cell.
Chemical Properties
| Molecular Formula | C12H12ClNO4 |
| Molecular Weight | 269.68 |
| CAS Numbers | 80263-73-6 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(OCCOCC)(=O)C=1OC=2C(N1)=CC(Cl)=CC2 |
Storage and Handling
0C Short Term, -20C Long Term
References
Fischer MJ, et al. Mechanism of action of the nonlipophilic antiallergic drug eclazolast [REV 2871] in the inhibition of mediator release in a mast cell model. Inflamm Res. 1999 ; 48[11] 569-574.